WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TSHA

Based on 8 analysts offering 12 month price targets for Taysha Gene Therapies Inc

Min Forecast
$8.00+38.17%
Avg Forecast
$10.63+83.51%
Max Forecast
$14.00+141.8%

Should I buy or sell TSHA stock?

Based on 8 analysts offering ratings for Taysha Gene Therapies Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TSHA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TSHA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TSHA stock forecasts and price targets.

TSHA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-10-21
lockedlocked$00.00+00.00%2025-10-17
lockedlocked$00.00+00.00%2025-10-02
Wells Fargo
Top 20%
81
Strong BuyMaintains$8.00+38.17%2025-08-13
Canaccord Genuity
Top 4%
97
Strong BuyMaintains$14.00+141.80%2025-08-13Find out why
Bank of America
Top 20%
81
Strong BuyInitiates Coverage On$8.00+38.17%2025-07-11

1 of 1

Forecast return on equity

Is TSHA forecast to generate an efficient return?

Company
-21.26%
Industry
252.48%
Market
227.91%
TSHA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TSHA forecast to generate an efficient return on assets?

Company
-14.71%
Industry
90.65%
TSHA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TSHA earnings per share forecast

What is TSHA's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
-$0.37
Avg 2 year Forecast
-$0.45
Avg 3 year Forecast
-$0.50

TSHA revenue forecast

What is TSHA's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$6.7M+5.59%
Avg 2 year Forecast
$4.4M-30.46%
Avg 3 year Forecast
$25.1M+298.54%
TSHA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TSHA revenue growth forecast

How is TSHA forecast to perform vs Biotechnology companies and vs the US market?

Company
44.56%
Industry
101.28%
Market
25.61%
TSHA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TSHA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TSHA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TSHA$5.79$10.63+83.51%Strong Buy
AGIO$27.27$32.13+17.80%Buy
BCRX$7.57$19.25+154.29%Strong Buy
PHVS$24.16$43.14+78.57%Buy
ATAI$4.29$14.00+226.34%Buy
View Top Biotech Stocks

Taysha Gene Therapies Stock Forecast FAQ

Is Taysha Gene Therapies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: TSHA) stock is to Strong Buy TSHA stock.

Out of 8 analysts, 5 (62.5%) are recommending TSHA as a Strong Buy, 3 (37.5%) are recommending TSHA as a Buy, 0 (0%) are recommending TSHA as a Hold, 0 (0%) are recommending TSHA as a Sell, and 0 (0%) are recommending TSHA as a Strong Sell.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.

What is TSHA's earnings growth forecast for 2025-2027?

(NASDAQ: TSHA) Taysha Gene Therapies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.6%.

Taysha Gene Therapies's earnings in 2025 is -$99,929,000.On average, 16 Wall Street analysts forecast TSHA's earnings for 2025 to be -$101,459,736, with the lowest TSHA earnings forecast at -$102,281,494, and the highest TSHA earnings forecast at -$97,789,216. On average, 15 Wall Street analysts forecast TSHA's earnings for 2026 to be -$124,277,220, with the lowest TSHA earnings forecast at -$144,958,132, and the highest TSHA earnings forecast at -$106,417,676.

In 2027, TSHA is forecast to generate -$137,617,093 in earnings, with the lowest earnings forecast at -$150,326,952 and the highest earnings forecast at -$109,293,830.

What is TSHA's revenue growth forecast for 2025-2027?

(NASDAQ: TSHA) Taysha Gene Therapies's forecast annual revenue growth rate of 44.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.61%.

Taysha Gene Therapies's revenue in 2025 is $6,310,000.On average, 16 Wall Street analysts forecast TSHA's revenue for 2025 to be $1,825,124,782, with the lowest TSHA revenue forecast at $1,151,009,205, and the highest TSHA revenue forecast at $4,314,230,125. On average, 14 Wall Street analysts forecast TSHA's revenue for 2026 to be $1,201,958,209, with the lowest TSHA revenue forecast at $0, and the highest TSHA revenue forecast at $4,314,230,125.

In 2027, TSHA is forecast to generate $6,888,524,392 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $26,529,091,275.

What is TSHA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TSHA) forecast ROA is -14.71%, which is lower than the forecast US Biotechnology industry average of 90.65%.

What is TSHA's Price Target?

According to 8 Wall Street analysts that have issued a 1 year TSHA price target, the average TSHA price target is $10.63, with the highest TSHA stock price forecast at $14.00 and the lowest TSHA stock price forecast at $8.00.

On average, Wall Street analysts predict that Taysha Gene Therapies's share price could reach $10.63 by Nov 5, 2026. The average Taysha Gene Therapies stock price prediction forecasts a potential upside of 83.51% from the current TSHA share price of $5.79.

What is TSHA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TSHA) Taysha Gene Therapies's current Earnings Per Share (EPS) is -$0.33. On average, analysts forecast that TSHA's EPS will be -$0.37 for 2025, with the lowest EPS forecast at -$0.37, and the highest EPS forecast at -$0.36. On average, analysts forecast that TSHA's EPS will be -$0.45 for 2026, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.39. In 2027, TSHA's EPS is forecast to hit -$0.50 (min: -$0.55, max: -$0.40).

What is TSHA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TSHA) forecast ROE is -21.26%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.